Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

NEWS

Veratramine ameliorates pain symptoms in rats with diabetic peripheral neuropathy by inhibiting activation of the SIGMAR1-NMDAR pathway.

PUBLISHED

01 December 2022

RECENT POSTS

Dr. Andrew Rice Becomes 20th President of the International Association for the Study of Pain

09 August 2024

IASP Awards Lakeisha Lewter with the Philip A. Spiegel Trainee Award

17 July 2024

IASP Remembers Professor Manfred Zimmermann

24 June 2024

IASP Co-Hosted an Event at the 77th World Health Assembly to Promote Pain Care

24 June 2024

Veratramine may have a potential therapeutic effect for diabetic peripheral neuropathy (DPN).

Posted in
Share this